Abstract
Nasal continuous positive air pressure (nCPAP) treatment may favourably affect serum levels of advanced glycation end products (AGEs) in patients with obstructive sleep apnoea syndrome (OSAS). At baseline, OSAS patients had significantly higher levels of AGEs than controls. Six months after nCPAP initiation, AGEs decreased significantly. nCPAP treatment could lower AGEs in patients with OSAS.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
There are no conflicts of interest in relation to the research presented.
Rights and permissions
About this article
Cite this article
Kotani, K., Kimura, S., Komada, I. et al. Continuous positive air pressure treatment reduces serum advanced glycation end products in patients with obstructive sleep apnoea syndrome: a pilot study. Prim Care Respir J 20, 336–337 (2011). https://doi.org/10.4104/pcrj.2011.00021
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.4104/pcrj.2011.00021
This article is cited by
-
Relationship between serum levels of endogenous secretory RAGE and blood pressure in male nondiabetic patients with obstructive sleep apnea
Journal of Human Hypertension (2015)
